PHASQ PhaseBio (PNK) drops 99% on Jan 15 2026: top loser, cash runway risk

PHASQ stock plunged 99.00% in market hours on Jan 15 2026, closing near USD 1e-06 on the PNK exchange in the United States. Volume was light at 2,500 shares versus an average of 22,310, and the one-day move left the stock well below its 50-day average of 0.000236 and 200-day average of 0.000666. Investors should view this as a top losers signal driven by bankruptcy-era liabilities, thin liquidity, and continuing clinical and funding uncertainty for PhaseBio Pharmaceuticals, Inc. (PHASQ)